2 results match your criteria: "LyonSud Hospital[Affiliation]"
A new approach for cognitive impairment pattern in chronic kidney disease.
Nephrol Dial Transplant
April 2024
Center for Research in Epidemiology and Population Health (CESP), Clinical Epidemiology Team, Paris-Saclay University, Versailles Saint-Quentin-en-Yvelines University, Inserm, Villejuif, France.
Background: Chronic kidney disease (CKD) is associated with an elevated risk of neurocognitive disorders (NCDs). It remains unclear whether CKD-related NCDs have a specific cognitive pattern or are earlier-onset phenotypes of the main NCDs (vascular NCDs and Alzheimer's disease).
Methods: We used the Mini Mental State Examination score (MMSE) to assess cognitive patterns in 3003 CKD patients (stage 3-4) followed up over 5 years in the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort.
Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
Inflamm Bowel Dis
February 2015
*Department of Gastroenterology, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France; †INSERM U1111 (CIRI), Lyon, France; ‡Cisbio Bioassays, Bagnols sur Cèze, France; and §Laboratory of Biochemistry, LyonSud Hospital, Pierre-Benite, France.
Background: Calprotectin and S100A12 (calgranulin C) are markers of gut inflammation. The aim was to compare the usefulness of serum and fecal calprotectin (fCal) and S100A12 in assessing the response to anti-TNF and in predicting relapse under maintenance therapy in Crohn's diseases (CD).
Methods: Thirty-two consecutive patients with CD were treated with adalimumab or infliximab.